Next-generation subretinal implant improves visual performance in preliminary trial

image.axd?id=a00c984c-144d-4434-a5d9-399708e595e1&t=636589841287770000
This single-arm clinical trial assessed the ability of the Retina Implant Alpha AMS (Retina Implant AG) to restore vision in 6 patients with end-stage retinitis pigmentosa. Study design The prospective, investigator-sponsored, interventional trial compared vision with the implant turned on versus with the implant turned off in the same eye. Each of the 6 patients received the Alpha AMS implant in their worse-seeing eye, which had bare light perception or no light perception at study entry. The main outcome measures were vision assessments, which included object recognition tasks, patient self-assessment of their mobility, as well as screen-based visual acuity testing including Basic Light and Motion testing as well as grating visual acuity. Outcomes During a 24-month follow-up period, the implant restored light perception and temporal resolution to all 6 participants. The ability to locate high-contrast tabletop objects was reestablished in all but 1 participant, whose implant was damaged intraoperatively. There were 2 incidents of conjunctival erosion, 1 macula-on retinal detachment and 2 cases of inadvertent damage to the implant during surgery. Limitations Because patients in this trial had bare light perception or no light perception at baseline, they may have had significant, permanent retinal damage prior to implantation. The surgery involves placing the implant underneath the fovea and is technically challenging. There were adverse events that arose due to the implantation process such as conjunctival dehiscence or erosion and retinal detachment. Clinical significance Patients who are blind from retinitis pigmentosa may have partial restoration of some visual precepts with this device. These early findings suggest the Alpha AMS performs at least as well as the previous generation Alpha IMS device, and with increased longevity.

https://www.lvcenter4sight.com/next-generation-subretinal-implant-improves-visual-performance-in-preliminary-trial/

Comments

Post a Comment

Popular posts from this blog

I Spy a Stye in Your Eye

Image
Written by Dr. David Evans Last modified on August 6, 2018 What’s that small, red, pimple-like bump on your eyelid that’s causing so much discomfort? It’s probably a stye (sometimes referred to as a sty or hordeolum). Besides being difficult to say 5 times quickly, an eye stye is a type of localized infection that can occur along the base of your eyelashes or underneath your eyelid. Styes that form along the base of the eyelashes are called external styes. They typically occur as a result of an infected eyelash hair follicle and look like the type of pimple that occurs when your pores are clogged with dirt and oil. Styes that form inside the eyelid are called internal styes. Similar to external styes, they are caused by an infection of an oil-producing gland behind the eyelid rather than an eyelash hair follicle. Internal styes result in generalized swelling of the eyelid rather than forming a pimple-like bump. Stye Symptoms As a stye develops, you might begin to experience pain
Read more

Post-LASIK Refraction and Pregnancy – Much Ado About Nothing?

Image
Written by Dr. David Evans Last modified on August 23, 2018 During pregnancy, women experience a drastic shift in their hormonal balance that has a ripple effect throughout the body. The spike in hormones like progesterone, estrogen, prolactin, oxytocin and relaxin are all important for a healthy pregnancy, but these increased levels can also impact gastrointestinal processes, blood pressure, skin pigmentation and, you guessed it, ocular health. Due to refractive changes that often occur during pregnancy, most refractive surgeons advise against LASIK during pregnancy, instead suggesting women wait several months after giving birth before considering treatment. Women who have already undergone LASIK may then wonder if the changes in ocular health that can occur during and after pregnancy impact post-LASIK refraction. New research presented by John Kanellopoulos, MD, New York University Medical School, NY, and LaserVision.gr seems to throw cold water on any such concern. The Eyes an
Read more